Price $45.65 |
Market Cap
2.76B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
8.9
|
P/B
3.43
|
P/S
0.6
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
7.3
|
Op. Cash Flow
470.2K
|
FCF
9.1
|
|
Op. Margin
10.80%
|
Net Margin
7.30%
|
ROE
32.80%
|
ROI
25.70%
|
|
ROA
11.20%
|
EPS Growth
-23.10%
|
Current Ratio
1.3
|
Debt/Equity
80.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | $13.41 | - | - | 139.2M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Dynatronics Corp (DYNT) | $0.15 | - | - | 2.4M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
